{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:27:18Z","timestamp":1792456038150,"version":"4.5.0"},"reference-count":180,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>(1) Background: Colchicine is a natural alkaloid with anti-inflammatory properties used to treat various disorders, including some skin diseases. This paper aims to incorporate all the available studies proposing colchicine as a treatment alternative in the management of cutaneous conditions. (2) Methods: In this systematic review, the available articles present in various databases (PubMed, Scopus-Embase, and Web of Science), proposing colchicine as a treatment for cutaneous pathological conditions, have been selected. Exclusion criteria included a non-English language and non-human studies. (3) Results: Ninety-six studies were included. Most of them were case reports and case series studies describing colchicine as single therapy, or in combination with other drugs. Hidradenitis suppurativa, pyoderma gangrenosum, erythema nodosum, erythema induratum, storage diseases, perforating dermatosis, bullous diseases, psoriasis, vasculitis, acne, urticaria, stomatitis, actinic keratosis, and pustular dermatosis were the main diseases discussed in literature. Although the therapeutic outcomes were variable, most of the studies reported, on average, good clinical results (4) Conclusions: Colchicine could be, as a single therapy or in combination with other drugs, a possible treatment to manage several skin diseases.<\/jats:p>","DOI":"10.3390\/pharmaceutics14020294","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T22:00:56Z","timestamp":1643320856000},"page":"294","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Colchicine in Managing Skin Conditions: A Systematic Review"],"prefix":"10.3390","volume":"14","author":[{"given":"Stefano","family":"Dastoli","sequence":"first","affiliation":[{"name":"Department of Health Sciences, Magna Graecia University, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Paul","family":"Nistic\u00f2","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Magna Graecia University, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Morrone","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliera di Cosenza, 87100 Cosenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8661-2822","authenticated-orcid":false,"given":"Cataldo","family":"Patruno","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Magna Graecia University, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Leo","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Magna Graecia University, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6746-6751","authenticated-orcid":false,"given":"Rita","family":"Citraro","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Magna Graecia University, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0858-7902","authenticated-orcid":false,"given":"Luca","family":"Gallelli","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Magna Graecia University, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-8123","authenticated-orcid":false,"given":"Emilio","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Magna Graecia University, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"De Sarro","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Magna Graecia University, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0434-1027","authenticated-orcid":false,"given":"Luigi","family":"Bennardo","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Magna Graecia University, 88100 Catanzaro, Italy"},{"name":"Azienda Ospedaliera di Cosenza, 87100 Cosenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/0378-6323.60552","article-title":"Colchicine in dermatology","volume":"76","author":"Rao","year":"2010","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/09546634.2019.1690621","article-title":"Efficacy and safety of colchicine in inflammatory skin diseases: A retrospective, monocentric study in a large tertiary center","volume":"32","author":"Anzengruber","year":"2021","journal-title":"J. Dermatol. Treat."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e12842","DOI":"10.1111\/dth.12842","article-title":"Treatment of telogen effluvium using a dietary supplement containing Boswellia serrata, Curcuma longa, and Vitis vinifera: Results of an observational study","volume":"32","author":"Nistico","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/0974-7753.203171","article-title":"Anagen effluvium following acute colchicine poisoning","volume":"8","author":"Combalia","year":"2016","journal-title":"Int. J. Trichol."},{"key":"ref_5","unstructured":"(2022, January 19). Colchicine, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Colchicine."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjd.15896","article-title":"Colchicine: An ancient drug with novel applications","volume":"178","author":"Dasgeb","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"ref_8","unstructured":"(2021, February 13). OCEBM Levels of Evidence\u2014Centre for Evidence-Based Medicine, University of Oxford. Available online: https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e12728","DOI":"10.1111\/dth.12728","article-title":"Update of calcineurin inhibitors to treat inverse psoriasis: A systematic review","volume":"31","author":"Dattola","year":"2018","journal-title":"Dermatol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Rendon, A., and Sch\u00e4kel, K. (2019). Psoriasis Pathogenesis and Treatment. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061475"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e13185","DOI":"10.1111\/dth.13185","article-title":"A novel vehicle for the treatment of psoriasis","volume":"33","author":"Dattola","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/09546630600999219","article-title":"Calcipotriol cream: A review of its use in the management of psoriasis","volume":"17","author":"Segaert","year":"2006","journal-title":"J. Dermatol. Treat."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/2327-6924.12443","article-title":"Psoriasis for the primary care practitioner","volume":"29","author":"Young","year":"2017","journal-title":"J. Am. Assoc. Nurse Pract."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Amoruso, G., Nistic\u00f2, S., Iannone, L., Russo, E., Rago, G., Patruno, C., and Bennardo, L. (2021). Ixekizumab May Improve Renal Function in Psoriasis. Healthcare, 9.","DOI":"10.3390\/healthcare9050543"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Iannone, L.F., Bennardo, L., Palleria, C., Roberti, R., De Sarro, C., Naturale, M.D., Dastoli, S., Donato, L., Manti, A., and Valenti, G. (2020). Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0241575"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2018.06.057","article-title":"Psoriasis: Which therapy for which patient: Psoriasis comorbidities and preferred systemic agents","volume":"80","author":"Kaushik","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/1574886314666190726155147","article-title":"A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case Report","volume":"15","author":"Dastoli","year":"2020","journal-title":"Curr. Drug Saf."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e14504","DOI":"10.1111\/dth.14504","article-title":"Emerging role of anti-IL23 in the treatment of psoriasis: When humanized is very promising","volume":"33","author":"Dattola","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/archderm.1976.01630280074028","article-title":"Letter: Colchicine therapy for psoriasis","volume":"112","author":"Gaylarde","year":"1976","journal-title":"Arch. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.1975.01630130035002","article-title":"Topical colchicine therapy for recalcitrant psoriasis","volume":"111","author":"Kaidbey","year":"1975","journal-title":"Arch. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2340\/0001555560515520","article-title":"Therapeutic trials with oral colchicine in psoriasis","volume":"60","author":"Wahba","year":"1980","journal-title":"Acta Derm. Venereol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/archderm.1981.01650120006008","article-title":"Treatment of generalized pustular psoriasis with methotrexate and colchicine","volume":"117","author":"Horiguchi","year":"1981","journal-title":"Arch. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF00403737","article-title":"Colchicine in generalized pustular psoriasis: Clinical response and antibody-dependent cytotoxicity by monocytes and neutrophils","volume":"274","author":"Zachariae","year":"1982","journal-title":"Arch. Dermatol. Res."},{"key":"ref_26","first-page":"777","article-title":"Psoriatic arthritis treated with oral colchicine","volume":"14","author":"Seideman","year":"1987","journal-title":"J. Rheumatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/ard.52.11.826","article-title":"Therapeutic value of colchicine in the treatment of patients with psoriatic arthritis","volume":"52","author":"McKendry","year":"1993","journal-title":"Ann. Rheum. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1346-8138.2004.tb00634.x","article-title":"Subcorneal Pustular Dermatosis Associated with Palmo-Plantar Pustular Psoriasis: Response to Colchicine Therapy","volume":"31","author":"Stefanaki","year":"2004","journal-title":"J. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1111\/ijd.14959","article-title":"Combination therapy with biologic and colchicine for generalized pustular psoriasis","volume":"59","author":"Taguchi","year":"2020","journal-title":"Int. J. Dermatol."},{"key":"ref_30","first-page":"348","article-title":"Reversal of Nephrotic Syndrome due to AA Amyloidosis in Psoriatic Patients on Long-Term Colchicine Treatment. Case report and review of the literature","volume":"82","author":"Kagan","year":"1999","journal-title":"Nephron Exp. Nephrol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s40257-016-0191-7","article-title":"Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects","volume":"17","author":"Raposo","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e13170","DOI":"10.1111\/dth.13170","article-title":"Effectiveness of brodalumab in acrodermatitis continua of Hallopeau: A case report","volume":"33","author":"Passante","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archderm.1982.01650190012009","article-title":"Treatment of Pustulosis Palmaris et Plantaris with Oral Doses of Colchicine","volume":"118","author":"Takigawa","year":"1982","journal-title":"Arch. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2133.1982.tb01740.x","article-title":"Failure of colchicine for palmo-plantar pustulosis","volume":"106","author":"Mann","year":"1982","journal-title":"Br. J. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2230.1983.tb01770.x","article-title":"Failure of colchicines for palmo-plantar pustulosis","volume":"8","author":"English","year":"1983","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2340\/00015555647678","article-title":"Treatment of pustulosis palmaris et plantaris with colchicine. A double-blind cross-over trial","volume":"64","author":"Reymann","year":"1984","journal-title":"Acta Derm Venereol."},{"key":"ref_37","first-page":"216","article-title":"Long-term colchicine for recalcitrant palmoplantar pustulosis: Treatment outcome in 3 patients","volume":"68","author":"Wong","year":"2001","journal-title":"Cutis"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-3083.2009.03197.x","article-title":"A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients","volume":"23","author":"Tekin","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0755-4982(06)74837-0","article-title":"Hidrad\u00e9nite eccrine neutrophilique idiopathique de l\u2019adulte d\u2019\u00e9volution prolong\u00e9e trait\u00e9e par colchicine. [Adult idiopathic neutrophilic eccrine hidradenitis treated with col-chicine]","volume":"35","author":"Belot","year":"2006","journal-title":"Presse Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/archdermatol.2012.2221","article-title":"Successful Treatment of Recurrent Idiopathic Plantar Eccrine Hidradenitis with Colchicine","volume":"148","author":"Scheer","year":"2012","journal-title":"Arch. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Del Duca, E., Morelli, P., Bennardo, L., Di Raimondo, C., and Nistic\u00f2, S.P. (2020). Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228436"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2017.16691","article-title":"Hidradenitis Suppurativa: Advances in Diagnosis and Treatment","volume":"318","author":"Saunte","year":"2017","journal-title":"JAMA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaad.2019.08.090","article-title":"Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis","volume":"82","author":"Goldburg","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s13668-020-00322-4","article-title":"Role of Vitamins in Skin Health: A Systematic Review","volume":"9","author":"Dattola","year":"2020","journal-title":"Curr. Nutr. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1080\/03007995.2020.1786681","article-title":"Safety profiles of biologic agents for inflammatory bowel diseases: A prospective pharmacovigilance study in Southern Italy","volume":"36","author":"Roberti","year":"2020","journal-title":"Curr. Med Res. Opin."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jaad.2019.08.089","article-title":"Hidradenitis suppurativa: Current and emerging treatments","volume":"82","author":"Goldburg","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"392","DOI":"10.23736\/S2784-8671.21.06887-5","article-title":"Psychological symptoms in dermatologic patients during the COVID-19 lockdown period: A double center experience","volume":"156","author":"Dattola","year":"2021","journal-title":"Ital. J. Dermatol. Venereol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4103\/ijdvl.IJDVL_69_18","article-title":"Hidradenitis Suppurativa: A Systematic Review and Meta-analysis of Therapeutic Interventions","volume":"85","author":"Tchero","year":"2019","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000332846","article-title":"The Anti-Inflammatory Drug Colchicine Lacks Efficacy in Hidradenitis Suppurativa","volume":"223","author":"Prens","year":"2011","journal-title":"Dermatology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/ijd.13428","article-title":"Hidradenitis suppurativa treated with tetracycline in combination with colchicine: A prospective series of 20 patients","volume":"56","author":"Armyra","year":"2017","journal-title":"Int. J. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Liakou, A.I., Kontochristopoulos, G., Agiasofitou, E., Tsantes, A.G., Papadakis, M., Marnelakis, I., Tsante, K.A., Kapsiocha, A., Katoulis, A., and Gregoriou, S. (2021). Colchicine Improves Clinical Outcomes and Quality of Life in Hidradenitis Suppurativa Patients: A Retrospective Study. J. Clin. Med., 10.","DOI":"10.3390\/jcm10204742"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.det.2011.09.001","article-title":"Acne Vulgaris: Pathogenesis, Treatment, and Needs Assessment","volume":"30","author":"Dawson","year":"2012","journal-title":"Dermatol. Clin."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1542\/peds.2019-2056L","article-title":"Current Issues in the Treatment of Acne Vulgaris","volume":"145","author":"Habeshian","year":"2020","journal-title":"Pediatrics"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10103-020-03063-6","article-title":"A new 675-nm laser device in the treatment of acne scars: An observational study","volume":"36","author":"Cannarozzo","year":"2021","journal-title":"Lasers Med Sci."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Fox, L., Csongradi, C., Aucamp, M., Du Plessis, J., and Gerber, M. (2016). Treatment Modalities for Acne. Molecules, 21.","DOI":"10.3390\/molecules21081063"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jaad.2019.01.092","article-title":"Acne vulgaris: What\u2019s new in our 40th year","volume":"82","author":"Harper","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_58","first-page":"46","article-title":"Daylight photodynamic therapy with 5-aminolevulinic acid 5% gel for the treatment of mild-to-moderate inflammatory acne","volume":"156","author":"Manfredini","year":"2021","journal-title":"Ital. J. Dermatol. Venerol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/000155599750010094","article-title":"Failure of Colchicine in the Treatment of Severe Acne Vulgaris","volume":"79","author":"Schepis","year":"1999","journal-title":"Acta Derm. Venereol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2230.1996.tb00160.x","article-title":"Acne conglobata: Treatment with isotretinoin, colchicines, and cyclosporine as compared with surgical intervention","volume":"21","author":"Jeong","year":"1996","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/000155598443196","article-title":"Treatment of Acne Vulgaris with Colchicine","volume":"78","author":"Sadjadi","year":"1998","journal-title":"Acta Derm. Venereol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jaad.2018.01.020","article-title":"Urticaria: A comprehensive review: Epidemiology, diagnosis, and work-up","volume":"79","author":"Antia","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/dth.15111","article-title":"Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19","volume":"34","author":"Passante","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2133.1989.tb04167.x","article-title":"Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine","volume":"120","author":"Lawlor","year":"1989","journal-title":"Br. J. Dermatol."},{"key":"ref_65","first-page":"1423","article-title":"Treatment of chronic urticaria with colchicine","volume":"10","author":"Pho","year":"2011","journal-title":"J. Drugs Dermatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e15119","DOI":"10.1111\/dth.15119","article-title":"Efficacy of the colchicine add-on therapy in patients with autoimmune chronic urticaria","volume":"34","author":"Nabavizadeh","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/09546630701499309","article-title":"Urticaria unresponsive to antihistaminic treatment: An open study of therapeutic options based on histopathologic features","volume":"19","author":"Criado","year":"2008","journal-title":"J. Dermatol. Treat."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40257-017-0251-7","article-title":"Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment","volume":"18","author":"Alavi","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jaad.2015.06.021","article-title":"Pathophysiology of pyoderma gangrenosum (PG): An updated review","volume":"73","author":"Braswell","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000441-199207000-00008","article-title":"Case Report: Severe Pyoderma Associated with Familial Mediterranean Fever\u2014Favorable Response to Colchicine in Three Patients","volume":"304","author":"Lugassy","year":"1992","journal-title":"Am. J. Med. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(95)90801-3","article-title":"Treatment of pyoderma gangrenosum with colchicine","volume":"345","author":"Paolini","year":"1995","journal-title":"Lancet"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000079897","article-title":"Treatment of Pyoderma gangrenosum with Low-Dose Colchicine","volume":"209","author":"Kontochristopoulos","year":"2004","journal-title":"Dermatology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-4632.2008.03949.x","article-title":"Penile pyoderma gangrenosum: Successful treatment with colchicine","volume":"47","author":"Parren","year":"2008","journal-title":"Int. J. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ad.2015.12.001","article-title":"Sweet Syndrome: A Review and Update","volume":"107","year":"2016","journal-title":"Actas Dermosifiliogr."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-2-34","article-title":"Sweet\u2019s syndrome\u2014A comprehensive review of an acute febrile neutrophilic dermatosis","volume":"2","author":"Cohen","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2133.1981.tb00785.x","article-title":"Treatment of acute febrile neutrophilic dermatosis (Sweet\u2019s syndrome) with colchicine","volume":"105","author":"Suehisa","year":"1981","journal-title":"Br. J. Dermatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2133.1983.tb04584.x","article-title":"Colchicine in the treatment of acute febrile neutrophilic dermatosis (Sweet\u2019s syndrome)","volume":"108","author":"Suehisa","year":"1983","journal-title":"Br. J. Dermatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2133.1999.02747.x","article-title":"Verret Colchicine for Sweet\u2019s syndrome. A study of 20 cases","volume":"140","author":"Maillard","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1067\/mjd.2002.121028","article-title":"Long-term suppression of chronic Sweet\u2019s syndrome with colchicine?","volume":"47","author":"Ritter","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e15171","DOI":"10.1111\/dth.15171","article-title":"Bullous Sweet syndrome in a patient with acute myeloid leukemia treated with midostaurin: Rapid response to acitretin and colchicine\u2014A case report","volume":"34","author":"Chiewchanvit","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e12811","DOI":"10.1111\/dth.12811","article-title":"Anti-interleukin 12\/23 in the treatment of erythema nodosum and Crohn disease: A case report","volume":"32","author":"Spagnuolo","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Cameli, N., Silvestri, M., Mariano, M., Bennardo, L., Nistic\u00f2, S., and Cristaudo, A. (2021). Erythema nodosum following the first dose of ChAdOx1-S nCoV-19 vaccine. J. Eur. Acad. Dermatol. Venereol.","DOI":"10.1111\/jdv.17762"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jama.1967.03130240098025","article-title":"Erythema nodosum treatment with colchicine","volume":"202","author":"Wallace","year":"1967","journal-title":"JAMA"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Schipani, G., DEL Duca, E., Todaro, G., Scali, E., Dastoli, S., Bennardo, L., Bonacci, S., DI Raimondo, C., Pavel, A.B., and Colica, C. (2020). Arsenic and chromium levels in hair correlate with actinic keratosis\/non melanoma skin cancer: Results of an observational controlled study. Ital. J. Dermatol. Venereol.","DOI":"10.23736\/S0392-0488.20.06600-6"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/curroncol28040213","article-title":"Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far?","volume":"28","author":"Bennardo","year":"2021","journal-title":"Curr. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Pentangelo, G., Nistic\u00f2, S., Provenzano, E., Cisale, G., and Bennardo, L. (2021). Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip. Medicina, 57.","DOI":"10.3390\/medicina57060563"},{"key":"ref_87","first-page":"s161","article-title":"Actinic Keratosis: Current Therapies and Insights into New Treatments","volume":"18","author":"Hashim","year":"2019","journal-title":"J. Drugs Dermatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/09546634.2016.1254328","article-title":"Real-world approach to actinic keratosis management: Practical treatment algorithm for office-based dermatology","volume":"28","author":"Dirschka","year":"2016","journal-title":"J. Dermatol. Treat."},{"key":"ref_89","first-page":"373","article-title":"Topical therapy for actinic keratoses, II: Diclofenac, colchicine, and retinoids","volume":"71","author":"Tutrone","year":"2003","journal-title":"Cutis"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000018407","article-title":"Topical colchicine therapy for actinic keratoses","volume":"200","author":"Etienne","year":"2000","journal-title":"Dermatology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/09546630152696314","article-title":"Efficacy and safety assessment of 0.5% and 1% colchicine cream in the treatment of actinic keratoses","volume":"12","author":"Akar","year":"2001","journal-title":"J. Dermatol. Treat."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"5918393","DOI":"10.1155\/2016\/5918393","article-title":"Topical Colchicine Gel versus Diclofenac Sodium Gel for the Treatment of Actinic Keratoses: A Randomized, Double-Blind Study","volume":"2016","author":"Faghihi","year":"2016","journal-title":"Adv. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/bjd.16824","article-title":"Effectiveness and safety of 0.5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: A randomized controlled trial","volume":"179","author":"Miola","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e12616","DOI":"10.1111\/dth.12616","article-title":"CO2 laser and photodynamic therapy: Study of efficacy in periocular BCC","volume":"31","author":"Mercuri","year":"2018","journal-title":"Dermatol. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/art.40375","article-title":"Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"70","author":"Zelger","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"104033","DOI":"10.1016\/j.lpm.2020.104033","article-title":"Management of cutaneous vasculitis","volume":"49","author":"Micheletti","year":"2020","journal-title":"Presse Med."},{"key":"ref_97","first-page":"301","article-title":"From gut to skin: The association between celiac disease and cutaneous abnormalities","volume":"67","author":"Abenavoli","year":"2021","journal-title":"Minerva Gastroenterol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00128071-200809020-00001","article-title":"Clinical Approach to Cutaneous Vasculitis","volume":"9","author":"Chen","year":"2008","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Abenavoli, L., Dastoli, S., Bennardo, L., Boccuto, L., Passante, M., Silvestri, M., Proietti, I., Potenza, C., Luzza, F., and Nistic\u00f2, S.P. (2019). The Skin in Celiac Disease Patients: The Other Side of the Coin. Medicina, 55.","DOI":"10.3390\/medicina55090578"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.clindermatol.2006.07.007","article-title":"Cutaneous vasculitis: Diagnosis and management","volume":"24","author":"Carlson","year":"2006","journal-title":"Clin. Dermatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.clindermatol.2019.07.028","article-title":"Erythema elevatum et diutinum as a systemic disease","volume":"37","author":"Sandhu","year":"2019","journal-title":"Clin. Dermatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1590\/abd1806-4841.20187470","article-title":"Erythema elevatum diutinum","volume":"93","author":"Dinato","year":"2018","journal-title":"An. Bras. Dermatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2230.1989.tb02611.x","article-title":"Erythema elevatum diutinum\u2014A case successfully treated with colchicine","volume":"14","author":"Henriksson","year":"1989","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_104","first-page":"1090","article-title":"A Case of Erythema Elevatum Diutinum with Pancyto-penia: Focus on Dapsone-Induced Hematologic Side Effects and Colchicine as a Safe Treatment Option","volume":"14","author":"Memet","year":"2015","journal-title":"J. Drugs Dermatol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40264-021-01071-1","article-title":"Emerging Skin Toxicities in Patients with Breast Cancer Treated with New Cyclin-Dependent Kinase 4\/6 Inhibitors: A Systematic Review","volume":"44","author":"Silvestri","year":"2021","journal-title":"Drug Saf."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/1534734618804982","article-title":"Vasculitis\u2014What Do We Have to Know? A Review of Literature","volume":"17","author":"Shavit","year":"2018","journal-title":"Int. J. Low. Extremity Wounds"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jaad.2020.06.062","article-title":"Immunoglobulin A expression in adult cutaneous leukocytoclastic vasculitis and its effect on hospital outcomes","volume":"83","author":"Hoffman","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/anr.1780321125","article-title":"Colchicine and leukocytoclastic vasculitis","volume":"32","author":"Plotnick","year":"1989","journal-title":"Arthritis Care Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0190-9622(85)70158-2","article-title":"Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis","volume":"13","author":"Callen","year":"1985","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archderm.1995.01690240061009","article-title":"Colchicine in the Treatment of Cutaneous Leukocytoclastic Vasculitis. Results of a prospective, randomized controlled trial","volume":"131","author":"Sais","year":"1995","journal-title":"Arch. Dermatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jaip.2018.05.006","article-title":"Mimickers of Urticaria: Urticarial Vasculitis and Autoinflammatory Diseases","volume":"6","author":"Davis","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaci.2018.09.007","article-title":"Treatment of urticarial vasculitis: A systematic review","volume":"143","author":"Kolkhir","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archderm.1985.01660060116035","article-title":"Urticarial vasculitis treated with colchicine","volume":"121","author":"Wiles","year":"1985","journal-title":"Arch. Dermatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1111\/1346-8138.15712","article-title":"Case of hypocomplementemic urticarial vasculitis with Sj\u00f6gren\u2019s syndrome successfully treated with oral corticosteroid and colchicine","volume":"48","author":"Fujii","year":"2021","journal-title":"J. Dermatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0190-9622(85)80499-0","article-title":"Urticarial vasculitis: Response to dapsone and colchicine","volume":"13","author":"Muramatsu","year":"1985","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2230.1991.tb01227.x","article-title":"The normocomplementemic urticarial vasculitis syndrome-report of a case and response to colchicine","volume":"16","author":"Asherson","year":"1991","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/art.38956","article-title":"The Clinical Spectrum and Therapeutic Management of Hypocomplementemic Urticarial Vasculitis: Data from a French Nationwide Study of Fifty-Seven Patients","volume":"67","author":"Jachiet","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00296-009-1173-3","article-title":"Beh\u00e7et\u2019s disease and celiac disease: A rare association or a possible link?","volume":"30","author":"Abenavoli","year":"2010","journal-title":"Rheumatol. Int."},{"key":"ref_119","first-page":"3","article-title":"One year in review 2020: Beh\u00e7et\u2019s syndrome","volume":"38","author":"Hatemi","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0190-9622(81)80269-1","article-title":"Beh\u00e7et\u2019s syndrome and treatment with colchicine","volume":"4","author":"Rogers","year":"1981","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_121","first-page":"344","article-title":"Use of colchicine in Beh\u00e7et\u2019s syndrome","volume":"37","author":"Sander","year":"1986","journal-title":"Cutis"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/s10165-009-0200-2","article-title":"Colchicine versus placebo in Beh\u00e7et\u2019s disease: Randomized, double-blind, controlled crossover trial","volume":"19","author":"Davatchi","year":"2009","journal-title":"Mod. Rheumatol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicinein Beh\u00e7et\u2019s syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000182257","article-title":"Randomized Trial of Pimecrolimus Cream plus Colchicine Tablets versus Colchicine Tablets in the Treatment of Genital Ulcers in Beh\u00e7et\u2019s Disease","volume":"218","year":"2009","journal-title":"Dermatology"},{"key":"ref_125","unstructured":"Tolaymat, L., and Hall, M.R. (2021). Pigmented Purpuric Dermatitis. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ad.2019.02.013","article-title":"Dermatosis purp\u00faricas pigmentadas: A Review of the Literature","volume":"111","author":"Biosca","year":"2020","journal-title":"Actas Dermo-Sifiliogr."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e13843","DOI":"10.1111\/dth.13843","article-title":"Granulomatous pigmented purpuric dermatosis favorably treated with the combination of colchicine and calcium dobesilate","volume":"33","author":"Bhandari","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_128","first-page":"324","article-title":"Colchicine as possible treatment of non-cryoglobulinaemic vasculitis in Sj\u00f6gren\u2019s syndrome","volume":"38","author":"Grasso","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/mrcr\/rxab041","article-title":"Successful treatment of IgA vasculitis with prolonged cutaneous manifestation with colchicine in a 10-year-old boy","volume":"6","author":"Okura","year":"2021","journal-title":"Mod. Rheumatol. Case Rep."},{"key":"ref_130","first-page":"482","article-title":"Successful treatment of chronic Henoch-Schonlein purpura with colchicine and aspirin","volume":"2","author":"Padeh","year":"2000","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/rheumatology\/40.12.1430","article-title":"Colchicine for the treatment of recurrent Henoch-Schonlein purpura in an adult","volume":"40","author":"Pyne","year":"2001","journal-title":"Rheumatology"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/0009922809337532","article-title":"Successful Treatment of Prolonged Henoch-Sch\u00f6nlein Purpura with Colchicine","volume":"48","author":"Saulsbury","year":"2009","journal-title":"Clin. Pediatr."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/archderm.1979.04010110009014","article-title":"Management of necrotizing vasculitis with colchicine. Improvement in patients with cutaneous lesions and Behcet\u2019s syndrome","volume":"115","author":"Hazen","year":"1979","journal-title":"Arch. Dermatol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s13063-020-04285-3","article-title":"Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: Azathioprine, colchicine, and dapsone","volume":"21","author":"Micheletti","year":"2020","journal-title":"Trials"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1529-8019.2010.01332.x","article-title":"Erythema nodosum and erythema induratum (nodular vasculitis): Diagnosis and management","volume":"23","author":"Gilchrist","year":"2010","journal-title":"Dermatol. Ther."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1111\/ajd.12494","article-title":"Treatment of nodular vasculitis with colchicine","volume":"58","author":"Wee","year":"2017","journal-title":"Australas. J. Dermatol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s40257-017-0278-9","article-title":"Primary Localized Cutaneous Amyloidosis: A Systematic Treatment Review","volume":"18","author":"Weidner","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_138","first-page":"A4727","article-title":"Primary localised cutaneous amyloidosis\u2014A systematic review","volume":"60","author":"Kaltoft","year":"2013","journal-title":"Dan. Med J."},{"key":"ref_139","first-page":"268","article-title":"Role of colchicine in primary localised cutaneous amyloidosis","volume":"61","author":"Chakravarty","year":"1995","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1055\/s-0040-1713130","article-title":"Cutaneous Sarcoidosis","volume":"41","author":"Caplan","year":"2020","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40257-019-00428-8","article-title":"Biologic Therapy in the Treatment of Cutaneous Sarcoidosis: A Literature Review","volume":"20","author":"Dai","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_142","first-page":"105","article-title":"Clinical resolution of facial cutaneous sarcoidosis with systemic colchicine and a topical corticosteroid ointment","volume":"34","author":"Wise","year":"2008","journal-title":"Compr. Ther."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"e14541","DOI":"10.1111\/dth.14541","article-title":"Hereditary angioedema type III, recurrent pregnancy loss and heterozygous MTHFR mutation","volume":"33","author":"Napolitano","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/07853890.2016.1162909","article-title":"Hereditary and acquired C1-inhibitor-dependent angioedema: From pathophysiology to treatment","volume":"48","author":"Zeerleder","year":"2016","journal-title":"Ann. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5114\/ceji.2015.50843","article-title":"Coexistence of hereditary angioedema in a case of familial Mediterranean fever with partial response to colchicine","volume":"40","author":"Bahceci","year":"2015","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/1346-8138.15647","article-title":"Clinical practice guide for the treatment of perforating dermatosis","volume":"47","author":"Kawakami","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/ddg.13561","article-title":"Treatment of acquired reactive perforating dermatosis\u2014A systematic review","volume":"16","author":"Schliemann","year":"2018","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e14492","DOI":"10.1111\/dth.14492","article-title":"Acquired perforating dermatosis: Response to colchicine","volume":"33","author":"Grover","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4103\/idoj.IDOJ_504_20","article-title":"Successful treatment of acquired perforating dermatosis with colchicine","volume":"12","author":"Gil","year":"2021","journal-title":"Indian Dermatol. Online J."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMicm1913412","article-title":"Linear IgA Bullous Dermatosis","volume":"382","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00105-019-4377-9","article-title":"Lineare IgA-Dermatose. [Linear IgA bullous dermatosis]","volume":"70","author":"Juratli","year":"2019","journal-title":"Hautarzt"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-4362.1997.00033.x","article-title":"Colchicine as a novel therapeutic agent in chronic bullous dermatosis of childhood","volume":"36","author":"Banodkar","year":"1997","journal-title":"Int. J. Dermatol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1001\/archderm.1984.01650430150027","article-title":"Linear IgA bullous dermatosis. Successful treatment with colchicine","volume":"120","author":"Aram","year":"1984","journal-title":"Arch. Dermatol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0190-9622(09)80120-5","article-title":"Successful treatment of chronic bullous dermatosis of childhood with colchicine","volume":"30","author":"Zeharia","year":"1994","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1525-1470.1999.99015.x","article-title":"Treatment of linear IgA bullous dermatosis of childhood with colchicine","volume":"16","author":"Ang","year":"1999","journal-title":"Pediatr. Dermatol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"e12748","DOI":"10.1111\/dth.12748","article-title":"Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers induced pemphigus: A case series and literature review","volume":"32","author":"Palleria","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0190-9622(99)70533-5","article-title":"Effect of colchicine in the subcorneal pustular dermatosis type of IgA pemphigus","volume":"40","author":"Hodak","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_158","first-page":"825","article-title":"Pemphigus foliaceus successfully treated with colchicine and topical corticosteroid","volume":"20","author":"Takahashi","year":"2010","journal-title":"Eur. J. Dermatol."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Bennardo, L., Passante, M., Cameli, N., Cristaudo, A., Patruno, C., Nistic\u00f2, S.P., and Silvestri, M. (2021). Skin Manifestations after Ionizing Radiation Exposure: A Systematic Review. Bioengineering, 8.","DOI":"10.3390\/bioengineering8110153"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1529-8019.2011.01438.x","article-title":"Colchicine in the management of mucous membrane pemphigoid","volume":"24","author":"Chaidemenos","year":"2011","journal-title":"Dermatol. Ther."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/ajd.12795","article-title":"Colchicine in dermatology: A review","volume":"59","author":"Robinson","year":"2018","journal-title":"Australas. J. Dermatol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jaad.2008.12.020","article-title":"A case of epidermolysis bullosa acquisita with clinical features of Brunsting-Perry pemphigoid showing an excellent response to colchicine","volume":"61","author":"Tanaka","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00375841","article-title":"Epidermolysis bullosa acquisita\u2013successful treatment with colchicine","volume":"286","author":"Megahed","year":"1994","journal-title":"Arch. Dermatol. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0190-9622(96)90013-4","article-title":"Colchicine for epidermolysis bullosa acquisita","volume":"34","author":"Cunningham","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00467-003-1310-2","article-title":"Colchicine therapy in amyloid nephropathy due to recessive dystrophic epidermolysis bullosa","volume":"18","author":"Kaneko","year":"2003","journal-title":"Pediatr. Nephrol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1346-8138.2005.tb00727.x","article-title":"Remission of Recalcitrant Epidermolysis Bullosa Acquisita (EBA) with Colchicine Monotherapy","volume":"32","author":"Arora","year":"2005","journal-title":"J. Dermatol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/1346-8138.13395","article-title":"Oral colchicine monotherapy for epidermolysis bullosa acquisita: Mechanism of action and efficacy","volume":"43","author":"Adachi","year":"2016","journal-title":"J. Dermatol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijwd.2016.04.001","article-title":"Colchicine may assist in reducing granulation tissue in junctional epidermolysis bullosa","volume":"2","author":"Kim","year":"2016","journal-title":"Int. J. Women\u2019s Dermatol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archderm.1980.01640360047016","article-title":"Treatment of Dermatitis Herpetiformis with Colchicine","volume":"116","author":"Silvers","year":"1980","journal-title":"Arch. Dermatol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40257-016-0202-8","article-title":"Subcorneal Pustular Dermatosis: A Review of 30 Years of Progress","volume":"17","author":"Watts","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_171","first-page":"56","article-title":"Colchicine in the treatment of subcorneal pustular dermatosis","volume":"61","author":"Pavithran","year":"2010","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_172","first-page":"73","article-title":"Colchicine treatment in children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: A multicenter study in Spain","volume":"8","author":"Camacho","year":"2020","journal-title":"Eur. J. Rheumatol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/ped.13265","article-title":"Is colchicine more effective to prevent periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis episodes in Mediterranean fever gene variants?","volume":"59","author":"Gunes","year":"2017","journal-title":"Pediatr. Int."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jbspin.2015.08.017","article-title":"Is colchicine an effective treatment in periodic fever, aphtous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome?","volume":"83","author":"Dusser","year":"2016","journal-title":"Jt. Bone Spine"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.semarthrit.2015.07.005","article-title":"Colchicine as a therapeutic option in periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome","volume":"45","author":"Aviel","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1651-2227.2008.00837.x","article-title":"Colchicine prophylaxis for frequent periodic fever, aphthous stomatitis, pharyngitis and adenitis episodes","volume":"97","author":"Tasher","year":"2008","journal-title":"Acta Paediatr."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1468-3083.2003.00614_1.x","article-title":"The effects of colchicine on neutrophil function in subjects with recurrent aphthous stomatitis","volume":"17","author":"Altinor","year":"2003","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"E189","DOI":"10.25011\/cim.v33i3.13725","article-title":"Comparison of colchicine versus prednisolone in recurrent aphthous stomatitis: A double-blind randomized clinical trial","volume":"33","author":"Pakfetrat","year":"2010","journal-title":"Clin. Investig. Med."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/archotol.1988.01860180085037","article-title":"Treatment of Severe Recurrent Aphthous Stomatitis with Colchicine","volume":"114","author":"Ruah","year":"1988","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0190-9622(94)70211-X","article-title":"Prevention of recurrent aphthous stomatitis with colchicine: An open trial","volume":"31","author":"Katz","year":"1994","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/2\/294\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:08:42Z","timestamp":1760134122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/2\/294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":180,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["pharmaceutics14020294"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14020294","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]}}}